DORNER-CIOSSEK; Cornelia

Patent Applications and Registrations

Patent applications and USPTO patent grants for DORNER-CIOSSEK; Cornelia.The latest application filed is for "4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament".

Company Profile

5.34.48

DORNER-CIOSSEK; Cornelia - Warthausen DE
Dorner-Ciossek; Cornelia - Ingelheim Am Rhein DE
Dorner-Ciossek; Cornelia - Ravensburg DE
Dorner-Ciossek; Cornelia - Goettingen DE
Dorner-Ciossek; Cornelia - Ingelheim DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
4-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament App 20210393644 - GIOVANNINI; Riccardo ; et al.	2021-12-23
4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament Grant 11,166,958 - Giovannini , et al. November 9, 2	2021-11-09
4-pyridinylmethyl-morpholine derivatives and the use thereof as medicament Grant 11,155,539 - Giovannini , et al. October 26, 2	2021-10-26
4-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicament Grant 11,104,670 - Giovannini , et al. August 31, 2	2021-08-31
Imidazopyridine derivatives and the use thereof as medicament Grant 10,849,907 - Giovannini , et al. December 1, 2	2020-12-01
4-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament App 20200121691 - GIOVANNINI; Riccardo ; et al.	2020-04-23
4-Pyridinylmethyl-Morpholine Derivatives and the use thereof as Medicament App 20200123141 - GIOVANNINI; Riccardo ; et al.	2020-04-23
4-Pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicament App 20200123140 - GIOVANNINI; Riccardo ; et al.	2020-04-23
Imidazopyridine derivatives and the use thereof as medicament App 20190175605 - GIOVANNINI; Riccardo ; et al.	2019-06-13
Inhibitors Of Beta-secretase App 20180344734 - Bukhtiyarov; Yuri ; et al.	2018-12-06
Inhibitors of beta-secretase Grant 9,949,975 - Bukhtiyarov , et al. April 24, 2	2018-04-24
Inhibitors Of Beta-secretase App 20170196867 - Bukhtiyarov; Yuri ; et al.	2017-07-13
Inhibitors of beta-secretase Grant 9,526,727 - Bukhtiyarov , et al. December 27, 2	2016-12-27
A-beta binding polypeptides Grant 9,211,330 - Park , et al. December 15, 2	2015-12-15
Inhibitors Of Beta-secretase App 20150239849 - Bukhtiyarov; Yuri ; et al.	2015-08-27
1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A modulators Grant 9,096,603 - Giovannini , et al. August 4, 2	2015-08-04
Compounds for the treatment of CNS disorders Grant 9,079,905 - Fuchs , et al. July 14, 2	2015-07-14
Inhibitors Of Beta-secretase App 20150150872 - Bukhtiyarov; Yuri ; et al.	2015-06-04
Inhibitors of beta-secretase Grant 9,018,391 - Bukhtiyarov , et al. April 28, 2	2015-04-28
Inhibitors of .beta.-secretase Grant 8,981,112 - Bukhtiyarov , et al. March 17, 2	2015-03-17
Compounds For The Treatment Of Cns Disorders App 20140350025 - GIOVANNINI; Riccardo ; et al.	2014-11-27
1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] Pyrimidin-4-one Derivatives And Their Use As Pde9a Modulators App 20140073641 - GIOVANNINI; Riccardo ; et al.	2014-03-13
Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture Grant 8,664,388 - Fuchs , et al. March 4, 2	2014-03-04
Inhibitors Of Beta-secretase App 20140057927 - Bukhtiyarov; Yuri ; et al.	2014-02-27
1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders Grant 8,648,085 - Eickmeier , et al. February 11, 2	2014-02-11
A-beta Binding Polypeptides App 20140030275 - PARK; John E. ; et al.	2014-01-30
1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulators Grant 8,623,879 - Giovannini , et al. January 7, 2	2014-01-07
Compounds for the treatment of CNS disorders Grant 8,623,901 - Giovannini , et al. January 7, 2	2014-01-07
Nucleic acid molecules encoding A-beta binding polypeptides Grant 8,614,308 - Park , et al. December 24, 2	2013-12-24
Inhibitors Of Beta-secretase App 20130289050 - Bukhtiyarov; Yuri ; et al.	2013-10-31
Substituted Amino-quinazolinones, Medicaments Comprising Said Compound, Their Use And Their Method Of Manufacture App 20130150387 - FUCHS; Klaus ; et al.	2013-06-13
Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture Grant 8,426,607 - Fuchs , et al. April 23, 2	2013-04-23
A-beta Binding Polypeptides App 20130017209 - PARK; John E. ; et al.	2013-01-17
A-beta binding polypeptides Grant 8,337,845 - Park , et al. December 25, 2	2012-12-25
Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture Grant 8,222,264 - Fuchs , et al. July 17, 2	2012-07-17
Compounds For The Treatment Of Cns Disorders App 20120115863 - Fuchs; Klaus ; et al.	2012-05-10
A-beta Binding Polypeptides App 20120058118 - PARK; John E. ; et al.	2012-03-08
Substituted Amino-benzimidazoles, Medicaments Comprimising Said Compound, Their Use And Their Method Of Manufacture App 20110288139 - Fuchs; Klaus ; et al.	2011-11-24
New Compounds For The Treatment Of Cns Disorder App 20110212960 - HEINE; Niklas ; et al.	2011-09-01
1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] Pyrimidin-4-one Derivates And Their Use As Pde9a Modulators App 20110184000 - Giovannini; Riccardo ; et al.	2011-07-28
New Compounds For The Treatment Of Cns Disorders App 20110082137 - GIOVANNINI; Riccardo ; et al.	2011-04-07
1, 5-dihydro-pyrazolo (3, 4-d) Pyrimidin-4-one Derivatives And Their Use As Pde9a Mudulators For The Treatment Of Cns Disorders App 20110015193 - Eickmeier; Christian ; et al.	2011-01-20
Inhibitors Of Beta-secretase For The Treatment Of Alzheimer's Disease App 20100298278 - Eickmeier; Christian ; et al.	2010-11-25
Substituted Amino-quinazolinones, Medicaments Comprising Said Compound, Their Use And Their Method Of Manufacture App 20100249158 - Fuchs; Klaus ; et al.	2010-09-30
Substituted 1,2-ethylenediamines, Methods For Preparing Them And Uses Thereof App 20100204160 - EICKMEIER; Christian ; et al.	2010-08-12
Compounds For The Treatment Of Alzheimer's Disease App 20100168070 - Heine; Niklas ; et al.	2010-07-01
Compounds For The Treatment Of Alzheimer's Disease App 20100144681 - Fuchs; Klaus ; et al.	2010-06-10
Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof Grant 7,713,961 - Eickmeier , et al. May 11, 2	2010-05-11
Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof App 20090325940 - Eickmeier; Christian ; et al.	2009-12-31
Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds Grant 7,534,787 - Bornemann , et al. May 19, 2	2009-05-19
Method of Treating Diseases and Conditions Associated with an Altered Level of Amyloid Beta Peptides and New Enolcarboxamide Compounds App 20090099159 - BORNEMANN; Klaus ; et al.	2009-04-16
Compounds For The Treatment Of Alzheimer's Disease App 20090042867 - Fuchs; Klaus ; et al.	2009-02-12
Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II App 20080293680 - Peters; Stefan ; et al.	2008-11-27
Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds App 20080139541 - Bornemann; Klaus ; et al.	2008-06-12
Method of treating diseases and conditions associated with an altered level of amyloid .beta. peptides and new enolcarboxamide compounds Grant 7,375,220 - Bornemann , et al. May 20, 2	2008-05-20
Statine derivatives for the treatment of Alzheimer's disease III Grant 7,238,774 - Peters , et al. July 3, 2	2007-07-03
Trisubstituted pyrimidines Grant 7,166,599 - Bornemann , et al. January 23, 2	2007-01-23
Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof App 20060223759 - Eickmeier; Christian ; et al.	2006-10-05
Statine derivatives for the treatment of Alzheimer's disease II App 20060160747 - Peters; Stefan ; et al.	2006-07-20
Statine derivatives for the treatment of Alzheimer's disease III App 20060100158 - Peters; Stefan ; et al.	2006-05-11
Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds App 20060040928 - Bornemann; Klaus ; et al.	2006-02-23
Substituted ethane-1,2-diamines for the treatment of Alzheimer's disease App 20060025345 - Peters; Stefan ; et al.	2006-02-02
Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds App 20050277635 - Bornemann, Klaus ; et al.	2005-12-15
Trisubstituted pyrimidines App 20050090486 - Bornemann, Klaus ; et al.	2005-04-28
Muscarinic M1 agonist as an inhibitor of beta-amyloid (A.beta.40 and A.beta.42)-synthesis Grant 6,573,276 - Hock , et al. June 3, 2	2003-06-03
Muscarinic M1 agonist as an inhibitor of beta-amyloid (ABeta40 and ABeta42)-synthesis App 20030050221 - Hock, Christoph ; et al.	2003-03-13
Gamma-secretase in vitro screening assay App 20030022251 - Fuchs, Klaus ; et al.	2003-01-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.